ClinicalTrialsFinder

Lung Neoplasms, Non-Small Cell Lung Cancer Clinical Trials in Nanchang, Jiangxi

1 recruitingNanchang, Jiangxi, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

Leptomeningeal MetastasisLung Neoplasms, Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University30 enrolled1 locationNCT07398599